Akanda (NASDAQ:AKAN) Downgraded by Wall Street Zen to “Strong Sell”

Wall Street Zen cut shares of Akanda (NASDAQ:AKAN) from a sell rating to a strong sell rating in a research note released on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Akanda in a report on Thursday, August 13th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Akanda Stock Performance

AKAN opened at $3.89 on Friday. Akanda has a 1-year low of $2.30 and a 1-year high of $209.02. The firm has a 50-day moving average price of $8.20 and a two-hundred day moving average price of $10.10.

Akanda (NASDAQ:AKAN) last released its quarterly earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.

Akanda Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.